Biomarkers in ultra low-risk myeloma

preview_player
Показать описание
Meral Beksac, MD, Ankara University, Ankara, Turkey, evaluates biomarkers of response in ultra low-risk multiple myeloma and the development of a genomic score that can be used for prognosis and treatment management. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Рекомендации по теме
visit shbcf.ru